Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Morning Review
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Transcripts
  • inderesTV
  • Portfolio
  • Forum
  • Q&A
  • About Us
    • Our Coverage
    • Team

IRLAB Therapeutics

1.60 SEK

-0.99 %

Less than 1K followers

IRLAB A

NASDAQ Stockholm

Biotechnology & Pharmaceuticals

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data

Valuation

Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for IRLAB Therapeutics

P/E

Median 2019-2025

EV/S

Median 2019-2024

EV/EBIT

Median 2019-2024

P/B

Median 2019-2025

 
2019202020212022202320242025
Share price (SEK)33.9539.6541.5436.167.0810.151.97
Shares43.750.554.854.954.954.984.9
Market cap1,482.12,002.42,276.91,986.6389.0557.6167.3
Enterprise value1,376.11,728.41,881.61,737.8305.3551.1-
EV/S52,928.2-9.128.453.75.8-
EV/EBITDAneg.neg.33.6neg.neg.neg.-
EV/EBITneg.neg.35.8neg.neg.neg.-
P/Eneg.neg.44.0neg.neg.neg.neg.
P/B8.155.765.706.833.3617.085.45
P/S57,004.5-11.032.568.55.92.9
Dividend yield0.0 %0.0 %0.0 %0.0 %0.0 %0.0 %0.0 %
Equity ratio87.4 %94.0 %84.6 %89.9 %65.4 %24.0 %22.2 %
Gearing ratio2.5 %0.8 %1.7 %1.4 %23.8 %185.1 %97.5 %
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.